India-Afghanistan Current Affairs - 2020
Category Wise PDF Compilations available at This Link
The Islamic Republic of Afghanistan has become the first country to recognize Indian Pharmacopoeia (IP) pursuant to the efforts of Department of Commerce and Union Ministry of Health and Family Welfare. The formal recognistion came from Afghanistan’s National Department of Regulation of Medicines and Health Products of Ministry of Public Health.
It will also be used based on requirement as reputable pharmacopoeia in laboratory of medicines and health products quality. With this, a new beginning has been made and Afghanistan has become the first country to recognize IP pursuant to the efforts of Department of Commerce and Ministry of Health and Family Welfare.
What is Indian Pharmacopoeia (IP)?
It is an officially recognized book of standards as per Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder. IP specifies the standards of drugs manufactured and marketed in India in terms of their identity, strength and purity. The 2nd Schedule of Drugs and Cosmetics Act, designates IP as an official book of standards for drugs imported and manufactured for sale, stock and exhibition for sale and distribution in India. The standards prescribed in IP are authoritative in nature and are enforced by regulatory authorities for quality control of medicines in India.
The quality, efficacy and safety of the medicines are important from healthcare perspective. In order to ensure the quality, efficacy and safety of medicinal products, the Indian Pharmacopoeia Commission (IPC) provides the legal and scientific standards in the form of Indian Pharmacopoeia (IP).
IPC’s Mission: To promote public and animal health in India by bringing out officially and authoritative accepted standards for quality of drugs including active pharmaceutical ingredients (APIs), excipients and dosage forms, used by patients, health professionals and consumers. This is achieved by developing standards for medicines and supporting their implementation. In addition to this, IPC also develops IP Reference Substances (IPRS) that act as fingerprint for identification of an article under test as well as its purity as prescribed in IP monographs.
Tags: Drugs and Cosmetics Act • India-Afghanistan • Indian Pharmacopoeia • Indian Pharmacopoeia Commission • IPC
On December 20, 2019, India, Afghanistan and Iran met at New Delhi to discuss the issues in the implementation of Chabahar port in Iran. The port is considered as a gateway of opportunities with Central Asian Nations by all the three countries.
The work of the Chabahar port is being conducted by the Port Global Ltd Company and the progress of the project was welcomed by all three countries. It was also agreed to include Mormugoa and New Mangalore ports of India under the Chabahar Agreement. It was also decided that a study will be conducted by Freight Forwarder Association in India to streamline the cargo transit in the country. The professionals of the meet also agree to finalize a protocol to harmonize transit of goods, consular matters and customs and till then the TIR convention is to be used.
The meeting also high lightened that the port has handled 5 lakh tons of cargo in 2019. It includes exports from Afghanistan from the port that began in February 2019.
The first meeting of the committee was held in October 2018. The third meeting is to be held in the first half of 2020.